Patient-Centered Formularies: Steps in the Right Direction, but Challenges Remain

2018-04-16T12:22:51+00:00April 11th, 2018|Viewpoints|

In a post on the IVI-sponsored Health Affairs featured blog series, Drugs and Medical Innovation, Jason Shafrin (IVI Director of Research) and Mark Linthicum (IVI Director of Scientific Communications) explore the role that formularies play in determining value for different stakeholders, and how unique, multi-stakeholder efforts can make formularies more patient-centered.

Read the full article here.